BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 19700761)

  • 21. Prostate cancer extracellular vesicles mediate intercellular communication with bone marrow cells and promote metastasis in a cholesterol-dependent manner.
    Henrich SE; McMahon KM; Plebanek MP; Calvert AE; Feliciano TJ; Parrish S; Tavora F; Mega A; De Souza A; Carneiro BA; Thaxton CS
    J Extracell Vesicles; 2020 Dec; 10(2):e12042. PubMed ID: 33408816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive Analysis of Secreted Protein, Acidic and Rich in Cysteine in Prostate Carcinogenesis: Development of a 3D Nanostructured Bone-Like Model.
    Ribeiro N; Costa-Pinheiro P; Henrique R; Gomez-Lazaro M; Pereira MP; Mansur AAP; Mansur HS; Jerónimo C; Sousa SR; Monteiro FJ
    J Biomed Nanotechnol; 2016 Aug; 12(8):1667-78. PubMed ID: 29342345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions between microenvironment and cancer cells in two animal models of bone metastasis.
    Blouin S; Baslé MF; Chappard D
    Br J Cancer; 2008 Feb; 98(4):809-15. PubMed ID: 18253114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential regulation of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-2 expression in co-cultures of prostate cancer and stromal cells.
    Dong Z; Nemeth JA; Cher ML; Palmer KC; Bright RC; Fridman R
    Int J Cancer; 2001 Aug; 93(4):507-15. PubMed ID: 11477554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of prostate cancer cell gene expression by cell-to-cell contact with bone marrow stromal cells or osteoblasts.
    Zhang S; Wang J; Bilen MA; Lin SH; Stupp SI; Satcher RL
    Clin Exp Metastasis; 2009; 26(8):993-1004. PubMed ID: 19787436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a unique set of genes altered during cell-cell contact in an in vitro model of prostate cancer bone metastasis.
    Wang J; Levenson AS; Satcher RL
    Int J Mol Med; 2006 May; 17(5):849-56. PubMed ID: 16596270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone marrow adipocytes promote the Warburg phenotype in metastatic prostate tumors via HIF-1α activation.
    Diedrich JD; Rajagurubandara E; Herroon MK; Mahapatra G; Hüttemann M; Podgorski I
    Oncotarget; 2016 Oct; 7(40):64854-64877. PubMed ID: 27588494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 9-kDa matricellular SPARC fragment released by cathepsin D exhibits pro-tumor activity in the triple-negative breast cancer microenvironment.
    Alcaraz LB; Mallavialle A; David T; Derocq D; Delolme F; Dieryckx C; Mollevi C; Boissière-Michot F; Simony-Lafontaine J; Du Manoir S; Huesgen PF; Overall CM; Tartare-Deckert S; Jacot W; Chardès T; Guiu S; Roger P; Reinheckel T; Moali C; Liaudet-Coopman E
    Theranostics; 2021; 11(13):6173-6192. PubMed ID: 33995652
    [No Abstract]   [Full Text] [Related]  

  • 29. Prostate cancer cell-derived urokinase-type plasminogen activator contributes to intraosseous tumor growth and bone turnover.
    Dong Z; Saliganan AD; Meng H; Nabha SM; Sabbota AL; Sheng S; Bonfil RD; Cher ML
    Neoplasia; 2008 May; 10(5):439-49. PubMed ID: 18472961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stromal factors involved in prostate carcinoma metastasis to bone.
    Cooper CR; Chay CH; Gendernalik JD; Lee HL; Bhatia J; Taichman RS; McCauley LK; Keller ET; Pienta KJ
    Cancer; 2003 Feb; 97(3 Suppl):739-47. PubMed ID: 12548571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C-C motif ligand 5 promotes migration of prostate cancer cells in the prostate cancer bone metastasis microenvironment.
    Urata S; Izumi K; Hiratsuka K; Maolake A; Natsagdorj A; Shigehara K; Iwamoto H; Kadomoto S; Makino T; Naito R; Kadono Y; Lin WJ; Wufuer G; Narimoto K; Mizokami A
    Cancer Sci; 2018 Mar; 109(3):724-731. PubMed ID: 29288523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discrepancy of biologic behavior influenced by bone marrow derived cells in lung cancer.
    Zhang J; Niu XM; Liao ML; Liu Y; Sha HF; Zhao Y; Yu YF; Tan Q; Xiang JQ; Fang J; Lv DD; Li XB; Lu S; Chen HQ
    Oncol Rep; 2010 Nov; 24(5):1185-92. PubMed ID: 20878109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SPARC mediates metastatic cooperation between CSC and non-CSC prostate cancer cell subpopulations.
    Mateo F; Meca-Cortés O; Celià-Terrassa T; Fernández Y; Abasolo I; Sánchez-Cid L; Bermudo R; Sagasta A; Rodríguez-Carunchio L; Pons M; Cánovas V; Marín-Aguilera M; Mengual L; Alcaraz A; Schwartz S; Mellado B; Aguilera KY; Brekken R; Fernández PL; Paciucci R; Thomson TM
    Mol Cancer; 2014 Oct; 13():237. PubMed ID: 25331979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of stromal-derived cytokines and growth factors in bone metastasis.
    David Roodman G
    Cancer; 2003 Feb; 97(3 Suppl):733-8. PubMed ID: 12548570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analyses of the role of endogenous SPARC in mouse models of prostate and breast cancer.
    Wong SY; Crowley D; Bronson RT; Hynes RO
    Clin Exp Metastasis; 2008; 25(2):109-18. PubMed ID: 18058030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cathepsin K inhibitors as treatment of bone metastasis.
    Le Gall C; Bonnelye E; Clézardin P
    Curr Opin Support Palliat Care; 2008 Sep; 2(3):218-22. PubMed ID: 18685424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of SPARC in the TRAMP model of prostate carcinogenesis and progression.
    Said N; Frierson HF; Chernauskas D; Conaway M; Motamed K; Theodorescu D
    Oncogene; 2009 Oct; 28(39):3487-98. PubMed ID: 19597474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progression.
    Derosa CA; Furusato B; Shaheduzzaman S; Srikantan V; Wang Z; Chen Y; Seifert M; Ravindranath L; Young D; Nau M; Dobi A; Werner T; McLeod DG; Vahey MT; Sesterhenn IA; Srivastava S; Petrovics G
    Prostate Cancer Prostatic Dis; 2012 Jun; 15(2):150-6. PubMed ID: 22343836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular pathway for cancer metastasis to bone.
    De S; Chen J; Narizhneva NV; Heston W; Brainard J; Sage EH; Byzova TV
    J Biol Chem; 2003 Oct; 278(40):39044-50. PubMed ID: 12885781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.